• AnaptysBio amended its bylaws to shift its fiscal year-end to June 30 from Dec. 31.
• The next fiscal year will start July 1, 2026.
• A Form 10-KT transition report will cover the six-month period from Jan. 1, 2026 to June 30, 2026.
• Quarterly reporting under the new fiscal year will begin with the quarter ending Sept. 30, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AnaptysBio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-234419), on May 21, 2026, and is solely responsible for the information contained therein.